Escalation and Ventilation Strategies for COVID-19 Patients
Coronavirus disease (COVID-19) is an infectious disease caused the SARS-CoV-2 virus. The majority of people infected with the virus experience mild symptoms and recover without receiving special treatment. However, special treatment, including mechanical ventilation, will be required by certain people to prevent mortality.
During this webinar, Dr Rachel Kaminski and Professor Joerg Steier summarise how healthcare professionals use escalation and ventilation strategies when managing COVID-19 patients based on personal experiences at the start of the COVID-19 pandemic, and published evidence.
Strategies included escalation between different areas such as respiratory high care area or escalation COVID-19 wards.
We hope that you found the content valuable. To ensure that we continue to provide topics and content of interest, we would very much value your feedback by completing a short questionnaire.
Dr Rachel Kaminski
Dr Kaminski graduated with a degree in medicine in 2006 from Imperial College London and a Respiratory BSc at Royal Brompton. In 2018 she was appointed as a Respiratory Consultant at Gloucestershire NHS Foundation Trust and is currently educational lead for the department. Her additional clinical responsibilities include running the severe asthma and bronchiectasis services and being lead clinician for transitional care from paediatrics. Rachel is a member of British Thoracic Society specialist advisory board for Cystic Fibrosis and an honorary lecturer at Bristol University.
Professor Joerg Steier
Professor Steier trained in medicine at the University of Leipzig/Saxony and has worked in Switzerland, USA and Germany. He holds a long-term research fellowship for the European Respiratory Society (ERS) in London and his research interests include respiratory physiology and sleep-disordered breathing. Joerg is currently Consultant at Guy’s & St Thomas’ NHS Foundation Trust in the Lane Fox Unit, a tertiary service for weaning and non-invasive ventilation. He is a member of the task force of the European Respiratory Society (ERS) on non-CPAP therapy, a member of the executive committee of the British Sleep Society (BSS) and is President of the BSS.